New York, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Global Pneumatic Nebulizers Market was valued at US$ 726.9 Mn in 2021 and is expected to reach US$ 1.5 Bn by 2032, finds Persistence Market Research in a recent market survey. As per the findings of the report hospitals & clinics segment by end-use will remain pivotal for the market as the bulk of revenue will be generated through this category. It is projected that the hospitals & clinics segment will account for a CAGR of 7.1% in 2032.
The growing number of Chronic Obstructive Pulmonary Disease (COPD) patients worldwide is the key factor in the high demand for Pneumatic Nebulizers.
The US to Command the Larger Proportion of Pneumatic Nebulizers Market throughout the Analysis Period
USA commands 29.3% of the market share and is expected to keep that position intact with an absolute opportunity growth of US$ 212 Mn to reach a valuation of US$ 439.5 Mn by 2032. Owing to the rapidly increasing requirement for pneumatic nebulizers in the treatment of Chronic Obstructive Pulmonary Disease (COPD) and Asthma, their demand in the USA is expected to increase. Nearly US$ 50 Bn is the annual direct costs associated with Chronic Obstructive Pulmonary Disease (COPD) in the U.S.
Request for SAMPLE copy of report: https://www.persistencemarketresearch.com/samples/33240
Pneumatic Nebulizers Market: Competition Insights
Key market players shaping the Pneumatic Nebulizers Industry are also focused on new product launches to expand their brand value and product portfolio in the Global Pneumatic Nebulizers during the upcoming 10-year epoch.
- Koninklijke Philips N.V.
- Omron Corporation
- General Electric
- Medline Industries Inc.
- Becton, Dickinson & Company
- Allied Healthcare Products
- Philips Respironics Inc.
- Briggs Healthcare
- Heyer Medical AG
- Medtronic PLC
- PARI Pharma GmbH
- Airssential Health Care
- Vectura Group Plc
- DeVilbiss Healthcare
- Flexicare Medical Ltd.
- Clement Clarke International
MAKE THIS REPORT YOUR OWN, Request Customization: https://www.persistencemarketresearch.com/request-customization/33240
Some of the key recent Developments in the Pneumatic Nebulizers Market include:
- In June 2021, Vectura Group Plc completed a buy-out of Skeypharma Production SAS, an oral manufacturing subsidiary based in Lyon, France. This announcement highlights the 2019 aim of the Vectura Group in order to become a completely inhalation focussed CDMO. This decision is set to positively impact Vectura Group Plc. during the upcoming forecast period.
- In March 2021, the authorization of PARI Pharma GmbH’s LAMIRA Nebulizer System in Japan was announced. The nebulizing system has been announced to deliver ARIKAYCE (amikacin liposome inhalation suspension) developed by Insmed.
- In January 2020, a new Automation Center in Tokyo was announced by OMRON Corporation, in order to enable customers to be included with the company for finding solutions to any challenges that may arise during the manufacturing process.
Get FULL ACCESS of report: https://www.persistencemarketresearch.com/checkout/33240
Persistence Market Research’s Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
Other Trending Reports:
- Orthopedic Trauma Devices Market
- Clinical Trial Management System Market
- Ophthalmic Devices Market
- Computerized Physician Order Entry Systems Market
- Cranio Maxillofacial Implants Market
- Disposable Plastic Blood Bags Market
- Human Insulin Market
- Surgical Lamps Market
- Delivery Systems in Personal Care Market
- Neurostimulation Devices Market
About Persistence Market Research:
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.
Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies’/clients’ shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.
Contact
Rajendra Singh
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com
